The development of a patient decision aid to reduce decisional conflict about antidepressant use in pregnancy.

ABSTRACT:

Background

People with moderate to severe depression in pregnancy must weigh potential risks of untreated or incompletely treated depression against the small, but uncertain risks of fetal antidepressant drug exposure. Clinical support alone appears insufficient for helping individuals with this complex decision. A patient decision aid (PDA) has the potential to be a useful tool for this population. The objective of our work was to use internationally recognized guidelines from the International Patient Decision Aids Standards Collaboration to develop an evidence-based PDA for antidepressant use in pregnancy.

Methods

A three-phased development process was used whereby, informed by patient and physician perspectives and evidence synthesis, a steering committee commissioned a

SUBMITTER: Hussain-Shamsy N 

PROVIDER: S-EPMC9099318 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature